Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
IPO Year:
Exchange: NYSE
Website: cigna.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/26/2024 | $400.00 | Overweight | Piper Sandler |
| 5/30/2024 | $388.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $393.00 | Overweight | Barclays |
| 2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
| 2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
| 1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
| 12/11/2023 | $335.00 → $341.00 | Hold → Buy | Jefferies |
| 8/18/2023 | Buy → Hold | Edward Jones | |
| 6/6/2023 | $320.00 | Neutral → Buy | BofA Securities |
Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025Confirming it is not Pursuing a Combination with Humana Inc.Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and DividendsBLOOMFIELD, Conn., Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group expects to reaffirm projected full year 2024 consolidated adjusted income from operations of at least $28.40 per share and adjusted EPS growth of at least 10% in 2025. Additionally, in light
Infirmary's hospitals, facilities and doctors on Alabama's Gulf Coast are now in-network for Cigna Healthcare MA customers MOBILE, Ala., Nov. 1, 2024 /PRNewswire/ -- Cigna Healthcare and Mobile-based Infirmary Health have reached an agreement that allows Cigna Healthcare's Medicare Advantage (MA) customers to have in-network access to Infirmary Health's hospitals, facilities and doctors. The agreement includes value-based aspects that are focused on improving customer health, lowering costs and achieving high-quality ratings. Infirmary Health is the largest nonprofit, non-gove
Total revenues for the third quarter 2024 increased 30% to $63.7 billionShareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per shareAdjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per shareReaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per shareBLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare. "Ou
BLOOMFIELD, Conn., Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and serv
54 community-based organizations receive funds to support the dietary needs of older adults BLOOMFIELD, Conn., Oct. 21, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE:CI), is investing $600,000 in community-based organizations this fall to address food insecurity among older Americans. Collectively, the funds are expected to impact more than 1.4 million people in need. "Food insecurity continues to be a major challenge for seniors in our country, and that can contribute to poor health outcomes among older populations due to them ei
BLOOMFIELD, Conn., Oct. 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a conference call the same day. Third quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 103
Plans available for every lifestyle and budget, including Medicare Advantage (MA) plans, Medicare Supplement plans, and standalone Prescription Drug Plans, all with competitive premiums and benefits.Many MA plans available for $0 premium; some give customers money back on their Social Security check.Dental, vision, and hearing benefits included in all Medicare Advantage (MA) plans."Living needs allowance" offered in many DSNPs.Customer support available 7-days a week to help guide Medicare Advantage shoppers during the Annual Enrollment Period.BLOOMFIELD, Conn., Oct. 1, 2024 /PRNewswire/ -- As the Medicare market continues to rapidly evolve, Cigna Healthcare℠ offers customers stable plans, a
Third annual Vitality In America study shows more people achieving high vitality, driven by improved sense of energy. While Gen Z adults continue to have the lowest overall vitality, they are feeling more confident, capable, and optimistic.People with high vitality are more than 5X as likely to wake up feeling well-rested, underlining strong link between sleep quality and vitality.Prolonged sitting during the workday is tied to low vitality, with one in 6 workers sitting for more than 8 hours per day.BLOOMFIELD, Conn., Sept. 26, 2024 /PRNewswire/ -- Although Americans continue to report concerning levels of stress, poor mental health, and loneliness, they are feeling more energized and sligh
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE:CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: Attributable to Andrea Nelson, Chief Legal Officer, The Cigna Group: "This action continues a troubling pattern from the FTC of unsubstantiated and ideologically-driven attacks on pharmacy benefit manager
Convene Business, Government and Community Leaders to Discuss Ways to Address the Mental Health Crisis Impacting Employees Across America WASHINGTON, Sept. 18, 2024 /PRNewswire/ -- Business Roundtable and The Cigna Group brought together senior business executives, federal policymakers and community leaders last night for a Workforce Mental Health Summit in the nation's capital. The event was part of the Business Roundtable Mental Health Initiative, a CEO-led effort to help companies promote and support employee mental health, championed by David M. Cordani, Chairman and CEO of The Cigna Group (NYSE:CI). During the event, leaders in business and government provided perspectives on the impact
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
Barclays initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $393.00
Cantor Fitzgerald upgraded The Cigna Group from Neutral to Overweight and set a new price target of $372.00 from $334.00 previously
RBC Capital Mkts upgraded The Cigna Group from Sector Perform to Outperform and set a new price target of $354.00 from $327.00 previously
Deutsche Bank upgraded The Cigna Group from Hold to Buy and set a new price target of $370.00 from $355.00 previously
Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $372.00 from $330.00 previously
Jefferies upgraded The Cigna Group from Hold to Buy and set a new price target of $341.00 from $335.00 previously
Edward Jones downgraded The Cigna Group from Buy to Hold
BofA Securities upgraded The Cigna Group from Neutral to Buy and set a new price target of $320.00
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 6.54% on an annualized basis producing an average annual return of 14.94%. Currently, Cigna Group has a market capitalization of $95.40 billion. Buying $100 In CI: If an investor had bought $100 of CI stock 20 years ago, it would be worth $1,660.76 today based on a price of $335.84 for CI at the time of writing. Cigna Group's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and re
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend. In the second quarter, UnitedHealth Group Inc (NYSE:UNH) and Elevance Health reported increasing pressure on Medicaid, creating uncertainty about when Medicaid margins will bottom out and when a potential recovery might occur. Centene Inc. (NYSE:CNC), Cigna Corp (NYSE:CI), and Molina Healthcare Inc. (NYSE:MOH) are trading at a 3x lower valuation than Elevance Health. While Elevan
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported. Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. Also Read: UnitedHealth Analysts Boost Their Fore
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis industry, especially if cannabis is federally legalized. The Role Of PBMs And Market Influence PBMs, such as UnitedHealth Group (NYSE:UNH)'s Optum, CVS Health (NYSE:CVS)'s CVS Caremark and Cigna (NYSE:CI)'s Express Scripts, negotiate discounts, create medication lists covered by insurance and reimburse pharmacies. The FTC's interim report revealed that these three PBMs manage 79% of U.S. prescription drug claims, consolidating their power and impacting dru
The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year investigation into whether the companies steer patients away from less-expensive medicines.https://www.wsj.com/health/pharma/ftc-to-sue-drug-managers-over-insulin-prices-b46af71f?mod=latest_headlines
Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.
Cigna Group (NYSE:CI) has outperformed the market over the past 15 years by 6.22% on an annualized basis producing an average annual return of 18.88%. Currently, Cigna Group has a market capitalization of $94.17 billion. Buying $100 In CI: If an investor had bought $100 of CI stock 15 years ago, it would be worth $1,351.94 today based on a price of $331.50 for CI at the time of writing. Cigna Group's Performance Over Last 15 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and re
The U.S. Federal Trade Commission (FTC) has highlighted significant concerns regarding consolidating pharmacies and health insurance companies, focusing on the influence of a few dominant pharmacy benefit managers (PBMs) on prescription drug prices. An interim report suggests that these PBMs have amassed considerable profits at the expense of independent pharmacies and consumers. The interim staff report, part of an ongoing inquiry launched in 2022 by the FTC, details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the U.S. Related: UnitedHealth’s OptumRx Unveils New Transparent Drug Pricing I
10-Q - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
10-Q - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
11-K - Cigna Group (0001739940) (Filer)
144 - Cigna Group (0001739940) (Subject)
Total revenues for the third quarter 2024 increased 30% to $63.7 billionShareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per shareAdjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per shareReaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per shareBLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare. "Ou
BLOOMFIELD, Conn., Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and serv
BLOOMFIELD, Conn., Oct. 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a conference call the same day. Third quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 103
Total revenues for the second quarter 2024 increased 25% to $60.5 billionShareholders' net income for the second quarter 2024 was $1.5 billion, or $5.45 per shareAdjusted income from operations1 for the second quarter 2024 was $1.9 billion, or $6.72 per share2024 outlook2 for adjusted income from operations1,2 is at least $28.40 per shareBLOOMFIELD, Conn., Aug. 1, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2024 results reflecting broad-based revenue and earnings growth across its businesses. "Our second quarter results underscore the strength of our diversified portfolio. We continue to deliver innovative solutions to meet the e
BLOOMFIELD, Conn., July 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on September 19, 2024 to shareholders of record as of the close of business on September 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and s
BLOOMFIELD, Conn., July 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day. Second quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 8028
Total revenues for the first quarter 2024 were $57.3 billionShareholders' net loss for the first quarter 2024 was $0.3 billion, or $0.97 per shareAdjusted income from operations1 for the first quarter 2024 was $1.9 billion, or $6.47 per share2024 outlook2 for adjusted income from operations1,2 increased to at least $28.40 per shareBLOOMFIELD, Conn., May 2, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses. "Our strong first quarter results reflect the performance of our Evernorth and Cigna Healthcare businesses, as well as our leadership in addressing the evo
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.) The majority of Cigna's core U.S. health insuran
BLOOMFIELD, Conn., April 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m
BLOOMFIELD, Conn., April 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2024 financial results on Thursday, May 2, 2024, and will host a conference call the same day. First quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 05022024 Replay(866) 407-9272 (Domestic)(203) 369-0617 (Internation
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz
Group Believes Board Has Disregarded Shareholders' Concerns by Appointing Solomon Trujillo as "Independent" Chairman Highlights Conflicting Financial Arrangements and Interlocks Among Board Members, Including Mr. Trujillo and Chief Executive Officer Marlow Hernandez Reiterates Demand that the Board Respect the Wishes of Shareholders by Making Necessary Leadership Changes or Reopening the Window to Nominate Director Candidates and Submit Proposals at 2023 Annual Meeting Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("C
PAVmed Inc. (NASDAQ:PAVM, PAVMZ))) (the "Company" or "PAVmed"), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid"), today announced the appointment of prominent healthcare services industry leader and president of Care Solutions for Evernorth, Joan Harvey, to its Board of Directors. Ms. Harvey will serve as a member of the Company's Audit and Compensation Committees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220215005417/en/PAVmed appoints Joan Harvey to its Board of Directors. (Photo: Business Wire) "Ms. Harvey brings a wealth of h
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors. "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we wo
BLOOMFIELD, Conn., July 30, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced several updates to its Board of Directors. Isaiah Harris, Jr., Chair of the Board of Directors, informed that Company that he intends to retire at the end of the year. Mr. Harris was appointed to the Board in 2005 and has served as Chair since 2009. During this time, Cigna significantly strengthened its core businesses, expanded its capabilities, and accelerated its growth plans, as the organization now serves more than 190 million customer relationships
BLOOMFIELD, Conn., Jan. 12, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced that George Kurian has been appointed to Cigna's Board of Directors. His appointment is effective March 1, 2021. Mr. Kurian currently serves as chief executive officer of NetApp, Inc., a cloud-led, data-centric, software company. Prior to joining NetApp in 2011, he served as vice president and general manager of Application Networking and Switching Technology at Cisco Systems. An engineer by training, Mr. Kurian has also previously held product strategy and consulting roles at Akamai Technologies, McKinsey & Company and Oracle Corporation. "With a wealth of product
BLOOMFIELD, Conn., Jan. 6, 2021 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) today announced that its Board of Directors has instituted a quarterly cash dividend and declared the first quarterly cash dividend of $1.00 per share of Cigna common stock to be paid on March 25, 2021 to shareholders of record as of the close of trading on March 10, 2021. "Cigna has a long track record of effective capital deployment, and our initiation of a quarterly dividend demonstrates our confidence in our ongoing ability to drive growth as we meet the needs of those we serve," said David M. Cordani, president and chief executive officer. "We are excited to share more at our
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
3 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
SC 13G - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Corp (0001739940) (Subject)
SC 13G - Cigna Corp (0001739940) (Subject)
SC 13G - Cigna Corp (0001739940) (Subject)
SC 13G/A - Cigna Corp (0001739940) (Subject)